VMP 39734411000001104

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Buspirone 5mg tablets
BNF code 0401020B0AAAAAA
Virtual Therapeutic Moiety Buspirone
Date identifier became valid 27 May 2021
Previous product identifier 321323009
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Buspirone hydrochloride
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 5.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Buspirone 5mg tablets (A A H Pharmaceuticals Ltd)
Buspirone 5mg tablets (Alissa Healthcare Research Ltd)
Buspirone 5mg tablets (Alliance Healthcare (Distribution) Ltd)
Buspirone 5mg tablets (Almus Pharmaceuticals Ltd)
Buspirone 5mg tablets (Medihealth (Northern) Ltd)
Buspirone 5mg tablets (Phoenix Healthcare Distribution Ltd)
Buspirone 5mg tablets (Sigma Pharmaceuticals Plc)
Buspirone 5mg tablets (Sigma Pharmaceuticals Plc)
Buspirone 5mg tablets (Strides Pharma UK Ltd)
Buspirone 5mg tablets (Viatris UK Healthcare Ltd)
Buspirone 5mg tablets (Zentiva Pharma UK Ltd)
Virtual Medicinal Product Packs
Buspirone 5mg tablets 30 tablet
Buspirone 5mg tablets 60 tablet
Buspirone 5mg tablets 90 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback